CD44 has exhibited positive correlations with tumor recurrence, high-grade SCCs, and poor prognosis [ 30].
Conventionally, low grade lesions have higher incidence of local recurrence, and high grade tumors present with higher incidence of local recurrence and distant metastasis.
However, multivariate analysis showed that only high EGFR overexpression, metastatic recurrence, high tumor grade and the combination of ≥ 2 affected markers were independent prognostic factors.
Because the median time to recurrence of high-grade retroperitoneal sarcoma is less than 5 years after definitive treatment, the intervals between follow-up evaluations should be 3 to 6 months for 5 years.
There was strong associations between lower UDP-glucuronosyltransferase 1A (UGT1A) expression and the risk of recurrence in high-grade NMIBC.
The data suggest that IMP3 staining could identify a subgroup of patients with poor prognosis and at risk of recurrence in high-grade gliomas.
The median time to recurrence of high-grade subcluster tumours was, as expected, decreased compared to PUNLMP subcluster tumours; 7 months and 63 months, respectively (P=0.006).
Our results suggest that IMP3 staining could increase the accuracy of histological diagnosis and tumor grading and could identify a subgroup of patients with poor prognosis and at a higher risk of recurrence in high-grade gliomas.
In the report from Bijker and colleagues [ 11], an analysis of recurrence rate in relation to histological subtype of low-grade DCIS revealed that none of 59 cases of clinging DCIS developed recurrence, in contrast to low-grade cribriform lesions, which exhibited similar recurrence rates to high grade DCIS.
However, the low-grade tumours seemed to have the same recurrence pattern as the high grade or PUNLMP tumours that they clustered together with.
This regimen was chosen for phase III comparison to observation until recurrence for women with high grade, uterus-limited, completely resected, LMS.
